Professional Documents
Culture Documents
BEYOND THE ABSENCE OF DISEASE - DR - JohnBeard
BEYOND THE ABSENCE OF DISEASE - DR - JohnBeard
BEYOND THE ABSENCE OF DISEASE - DR - JohnBeard
Disease
John Beard
Recent frameworks for thinking about aging
and health
National Academy of Medicine 2021
WHO 2015
But after just a few years……
The science is advancing so quickly that it is starting
to challenge the way we think about health itself:
• Geroscience
Hallmarks of Aging
Symptom
Threshold
Age
Chronic disease
Chronic
disease
expression
Symptom
Threshold
Age
Chronic disease
Chronic
disease
expression
Symptom
Threshold
Age
Chronic disease
Chronic
disease
expression
Symptom
Threshold
Age
Chronic disease
Chronic
disease
expression
Symptom
Threshold
Age
Chronic disease
Chronic
disease
expression
Symptom
Threshold
Age
Chronic disease
Chronic
disease
expression
Symptom
Threshold
Age
Recent frameworks for thinking about aging
and health
20
Capacity across the life course
65 and above
Early
Prenatal Develop- Maturation Robust and stable Age-related declines
ment
Significant losses
Mean Capacity
Early
Prenatal Develop- Maturation Robust and stable Age-related declines
ment
v Significant losses
Interventions to foster resilience and capacity
Mean Capacity
SHARE
Germany Greece Israel Italy Netherlands Portugal Slovenia Spain Sweden Switzerland
Participants 3,423 2,883 2,585 3,209 3,174 2,168 3,779 3,302 3,964 1,605
Waves 8 6 6 8 8 4 5 8 8 8
Ages (years) ≥50 ≥50 ≥50 ≥50 ≥50 ≥50 ≥50 ≥50 ≥50 ≥50
Commenced 2004 2004 2005 2004 2004 2011 2011 2004 2004 2004
Bifactor CFA
ELSA
ELSA
Vitality/
DNA Integrity Proteostasis Glycans
• Nuclear Stem cell
Resilience
• Mitochondrial exhaustion
Cellular
senescence/SASP
Intercellular
Epigenetic communication
changes (pro-inflammatory
(Methylation) Microbiome mediators)
Genetic inheritance
Early
Prenatal Develop- Maturing Age-related declines
ment ation
Significant losses
Mean Overt
Capacity
Mean
Vitality/Resilience
.5
.5
Mean factor score
0
-.5
-.5
-.5
-1
-1
-1
-1.5
-1.5
-1.5
60 65 70 75 80 85 90 60 65 70 75 80 85 90 60 65 70 75 80 85 90
Age Age Age
.5
.5
Mean factor score
0
0
-.5
-.5
-.5
-1
-1
-1
-1.5
-1.5
-1.5
60 65 70 75 80 85 90 60 65 70 75 80 85 90 60 65 70 75 80 85 90
Age Age Age
• Public health/epidemiology
– Behavioral risk factors
– Stratification, comparison between interventions
• Meaningful clinical/research endpoints (ICD
code MG2A)
– Health system funding mechanisms
• Better characterise relationship of overt
capacities with biological changes
– The real outcome for geroscience
Collaborators
• No validated instrument
• Still unclear conceptualization (e.g. personality
traits, knowledge, vitality, other)
• What about the life course?
• Language (e.g. resilience, reserves)
• Functional ability
Decomposing the life-course inequalities in
intrinsic capacity, China, 2011–2013
Significant losses
Mean Capacity
Mean Resilience
Significant losses
Mean Capacity
Mean Resilience
Robustness = D
Resilience = W+R
Why do we need to move on
from a disease-based paradigm?